by Nassir Ghaemi | Oct 18, 2022 | Curbside Consults
Q. Is psychotic depression yet another form of depression? Or is psychotic depression the same as manic depression? What is the difference between the two? I know that depression is qualified as neurosis and manic depression as psychosis. What about psychotic...
by Nassir Ghaemi | Jun 16, 2022 | Curbside Consults
Q: I wanted to ask about integrating the things you teach into my learning and practice as an upcoming resident. Lots of what you say is in conflict with what is traditionally taught, and I feel that I will just end up getting confused and my preceptors will perceive...
by Nassir Ghaemi | May 6, 2022 | Curbside Consults
Q: I have a 17 y/o girl that refuses to take olanzapine because at the John Hopkins clinic she was given a list of medications that she should avoid because they can increase QTC. She has a mitral valve prolapse, asymptomatic but causes a heart murmur. I don’t...
by Nassir Ghaemi | Nov 4, 2021 | Curbside Consults
Q; Never heard of chronic involutional melancholia. I give some activating drugs like venlafaxine or duloxetine for new onset of melancholia and do check-up for signs of any type of dementia and consider lithium and other brain supplements for dementia prevention. PL:...
by Nassir Ghaemi | Oct 25, 2021 | Curbside Consults
Q. The following patient was referred to me and is unfortunately a very typical case of the standards of current practice: Patient states he/she is seeking tools for continued good health. Patient willing to discontinue some medications, needs medication evaluation...
by Nassir Ghaemi | Oct 7, 2021 | Curbside Consults
Question: I would like to ask you one question regarding your differentiation between “symptomatic” drugs like monoamine-agonists or dopamine-inhibitors and second messenger modulators, the latter showing some ability to modify the disease process as such....
